Vivecor, a medical device company, filed a lawsuit against apple, accusing Apple watch of infringing three of its patents. The company filed a lawsuit in the Western District Court of Texas on Monday, claiming that the ECG features of Apple watch series 4 and later infringed its intellectual property rights related to the use of wearable sensors to improve cardiac monitoring technology. < / P > < p > according to the lawsuit, alivecor patents numbered 10595761, 10638941 and 9572499 – “explain the technical state of arrhythmia diagnosis, the limitations of known diagnostic techniques and diagnostic devices, and the need for inventors to improve diagnostic techniques and devices.”. < / P > < p > all three patents focus on monitoring arrhythmias, or irregular heartbeats. The patented technology includes the use of wearable device data to help diagnose the condition. < / P > < p > “(patent) claims are new and unconventional and focus on specific means and methods of using special sensors in wearable devices to improve existing cardiac monitoring technology,” the lawsuit wrote. Alivecor claims that apple is aware of all three patents. As a result, it accused apple of intentionally infringing and continuing to knowingly infringe these patents through its apple watch product line, including the apple watch series 5 specifically mentioned in the lawsuit. < / P > < p > alivecor is a manufacturer of various cardiac monitoring devices and the first consumer ECG device to appear, which has been approved by the food and Drug Administration (FDA). But unlike the apple watch, kardiaband needs to be approved by the user’s doctor. < / P > < p > after the first ECG feature was launched on Apple watch series 4, livecor pulled kardiaband out of sales, saying it was focused on expanding the capabilities of other mobile cardiac monitoring systems. Spontaneous combustion at a Guangzhou Motor vehicle intersection and other traffic lights in Shenzhen